ONdrugDelivery’s Post

We have developed a wearable drug delivery platform that utilizes advanced UV-C LED technology for automatic, verified disinfection. This innovation ensures a sterile fluid path and enhances patient safety, making self-administration of injectable medications more reliable and user-friendly.   Why It Matters:   - Eliminates user error and enhances safety - Provides consistent and reliable sterilization - Improves treatment adherence and patient outcomes   Learn more about how LTS is transforming healthcare with groundbreaking UV sterilization technology in our Sorrel™ Wearable Injectors. Check out the detailed research behind this innovation and read our in-depth insight article here: https://lnkd.in/e6AjEF-u  #lts #obds #obi #cdmo #pharma #HealthcareInnovation #DrugDelivery #Biotechnology #UVSterilization #PatientCare #SorrelWearableInjector

Wearable Injectors Market: Revolutionizing Drug Delivery! 📥 Download the PDF: https://lnkd.in/gfgK54pN The global Wearable Injectors Market is on a rapid growth trajectory, expected to skyrocket from USD 8.4 billion in 2023 to an impressive USD 15.1 billion by 2029, at a CAGR of 10.3%. 💥 As healthcare embraces innovation, wearable injectors are transforming drug delivery for conditions like Diabetes, Immuno-Oncology, Cardiovascular diseases, and Chronic Pain. With advancements in on-body and off-body injectors and evolving technologies such as spring, motor drive, expanding battery, and rotary pump systems, patient care is being revolutionized, whether in hospitals, clinics, or at home. 🏥🏠 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Amgen. Medtronic Insulet Corporation Ypsomed AG United Therapeutics Corporation Enable Injections, Inc. CeQur Sensile Medical ATS Automation, Inc West Pharmaceutical Services Tandem Diabetes Care Zealand Pharma Sonceboz E3D Elcam Drug Delivery Devices BESPAK EUROPE LIMITED Stevanato Group NEUMA Explore how these devices are reshaping patient experience and treatment outcomes! 🌍💉 #WearableInjectors #MedTech #DrugDelivery #HealthcareInnovation #DiabetesCare #Oncology #Cardiovascular #ChronicPain #Homecare #MedicalDevices

𝐖𝐞𝐚𝐫𝐚𝐛𝐥𝐞 𝐈𝐧𝐣𝐞𝐜𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $𝟏𝟓.𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟗 𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑷𝑫𝑭 𝑩𝒓𝒐𝒄𝒉𝒖𝒓𝒆: https://bit.ly/3yvDrNS The global wearable injectors market in terms of revenue was estimated to be worth $8.4 Billion in 2023 and is poised to reach $15.1 Billion by 2029, growing at a CAGR of 10.3% from 2023 to 2029. Wearable Injectors Market by Type(On-body, Off-body), Technology (Spring, Motor Drive, Expanding Battery, Rotary Pump), Indications (Diabetes, Immuno- Oncology, Cardiovascular, Chronic Pain), End Users (Hospital & Clinic, Homecare) - Global Forecast to 2029 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Amgen. Medtronic Insulet Corporation Tandem Diabetes Care United Therapeutics Corporation AbbVie. Gerresheimer Becton, Dickinson and Company West Pharmaceutical Services Ypsomed AG Enable Injections, Inc. Subcuject ApS CeQur MannKind Corporation Sonceboz CC Bio E3D Elcam Drug Delivery Devices Stevanato Group Debiotech SA Bexson Biomedical NEMERA LTS Lohmann Therapie-Systeme AG Kymanox NOVO Engineering, Inc. EOFlow Bexson Biomedical NEMERA LTS Lohmann Therapie-Systeme AG Kymanox #wearableinjectors #medicaltechnology #healthcareinnovation #drugdelivery #wearabledevices #medtech #healthtech #patientcare #injectiontechnology #pharmaceuticals #digitalhealth #healthcaretech

𝐖𝐞𝐚𝐫𝐚𝐛𝐥𝐞 𝐈𝐧𝐣𝐞𝐜𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $𝟏𝟓.𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟗 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: bit.ly/3SGoRdg The global wearable injectors market in terms of revenue was estimated to be worth $8.4 Billion in 2023 and is poised to reach $15.1 Billion by 2029, growing at a CAGR of 10.3% from 2023 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Amgen Medtronic Insulet Corporation Tandem Diabetes Care United Therapeutics Corporation AbbVie #WearableInjectorsMarket

Global #Clinical #Trial #Imaging Market: By Service (Clinical Trial Design and Consultation Services, Reading and Analytical Services, Project and Data Management, System and Technology Support Services), By Modality (Computed Tomography, Ultrasound, Magnetic Resonance Imaging, Positron Emission Tomography, Echocardiography, X-Ray, Other Modalities), By End-Use (Pharmaceutical Companies, Medical Device Manufacturers, Academic and Government Research Institutes, Biotechnology Companies, Contract Research Organizations, Other End-Users), and Region – Cumulative Growth Opportunities Analysis, Size, Share, Trends, and Industry Forecast Till 2030. By:Analytical Market Research Read More Info:https://lnkd.in/dy4TkaSS Key Players: IXICO plc; Navitas Life Sciences; Resonance Health Ltd; ProScan Imaging; Radiant Sage Ventures; Medpace Pharma; Biomedical Systems Corp; Circle Cardiovascular Imaging ; Intrinsic Medical Imaging; BioTelemetry, Inc. #marketgrowth #marketshare #marketsize #marketdemands #marketforecast #marketstretargy #marketanalysis #markettrends #market

🔬 The Talisman CGM device from GlucoModicum Ltd will be upping manufacturing efforts of following strong clinical data and a recently closed funding round, backed by a consortium of international investors and family offices. This will support further optimisation, manufacturing investments and a pivotal clinical trial of the device. 💬 Jokke Mäki, managing director, commented: "That investment also enables us to make more investments to optimise the performance further, and then it enables us to move and make relevant investments to mass manufacturing." 🔗 Read more: https://lnkd.in/ddMD7Z4h #MedicalDevices #MedicalDevice #Medicine #TechNews #Funding #MedTechFunding #FundingRound #AngelInvestment #GSCapitalConnect

According to our research the global market for medical devices is estimated at US$ 603 billion in the year 2023 and will be growing at a CAGR of 5% during next six years. #PharmaceuticalEquipment #UltrasonicCleaner #MedicalDevices #GlobalMarket #HealthcareInnovation #Sterility #LaboratoryEquipment #PharmaceuticalPackaging #CleanTechnology #MarketGrowth

My latest piece for Pharma-Sources Drug delivery is about improving the efficacy and safety of therapeutics by getting the right dose of the right drug to the right place at the right rate and time. Approaches to drug delivery have existed for many hundreds of years; Egyptian physicians created oral tablets and ointments, and physicians began to use intravenous delivery after the circulatory system was first described in 1657. Controlled release technologies date back to the mid-1900s. MEMS are small, integrated devices that combine electrical and mechanical components, and have been made possible by the advances in microfluidics and electronics miniaturisation. MEMS devices can be implantable or wearable, and have applications in chronic and long-term disease. They can deliver drugs to specific locations, and some can deliver more than one drug. Those with integrated sensors can tailor delivery rates to the patient's needs based on detection of vital signs or biomarkers. https://lnkd.in/ePjZz6qW

History in Making for the Medi-Tech Industry! Department of Pharmaceutical( DoP) under the visionary leadership of Secretary #DrArunishChawla undertook the mammoth exercise of organizing the #MediTech #Stackathon on May 8, 2024 in New Delhi in association with #CII. For the first time scientific segregation of the sector was done into 8 categories namely, #imagingdevices, #criticalcare, cancer therapy, assistive medical devices, body implants, surgical & hospital equipment, consumables & disposable and IVD diagnostics & reagents.  The aim of the Stackathon was to bring competing companies from each segment to brainstorm and collectively map and analyse the #valuechain of specialized technology platforms, components, sub-components and raw materials and come up with recommendations that will propel the growth of innovation based value added local manufacturing. #WiproGEHealthcare had the privilege to lead the Imaging devices segment and participate actively in the critical care segment along with other MNC and domestic players. Going forward, DoP will be organising segment wise workshops to build on the Stackathon findings, bridge the gaps and strengthen the value chain analysis to decide on the production linked and research linked incentive schemes. The work done under #SCALE Committee under the aegis of #DPIIT & #FICCI under the chairmanship of Dr Pawan Goenka to identify the value chain for imaging, implants & surgical equipment and IVDs eased the exercise during the Stackathon. Pawan Goenka GE HealthCare India Shuba Nagesh Shishir Gupta Chaitanya Sarawate Rajat Ghai Krishna BS Blaise Cardozo Srinivasa Murthy Dorai Subramaniam Meghna Mukhopadhyay Vijay Aralikatti #DepartmentofPharmaceuticals #NPPA

Aesthetic Devices Consumption Market Growth and Key Players Visti Us- https://lnkd.in/e3KdnVrA The aesthetic devices consumption market is witnessing significant growth due to increasing demand for non-invasive cosmetic procedures. Factors such as rising awareness of aesthetic treatments, advancements in technology, and a growing focus on personal appearance are driving market expansion. Key players in the market include Allergan, Lumenis, Hologic, Inc., Syneron Candela-Candela, Cutera, Inc., Sciton, Venus Aerospace Concept, Merz Aesthetics Pharmaceuticals, and Revance Therapeutics among others. The competitive landscape is driven by innovation and strategic partnerships. #AestheticDevices #CosmeticMarket #BeautyTrends #TechInnovation